Evidence map›Paper›PMID 27932045›Full record

ArticleActa orthopaedica et traumatologica turcica2016

Serum and knee synovial fluid matrixmetalloproteinase-13 and tumor necrosis factor-alpha levels in patients with late stage osteoarthritis.

Kenan Özler, Erdem Aktaş, Çiğdem Atay, Barış Yılmaz, Murat Arıkan, Şafak Güngör

RetractedOpen access · greenAbstract readRetracted Publication
In one paragraph

Article in Acta orthopaedica et traumatologica turcica, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
6.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 51 citations in OpenAlex.

  1. Pooled it
  2. Journal of clinical medicine · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Adipokines: New Therapeutic Target for Osteoarthritis?Current rheumatology reports · 2019
    Review
  14. Article
  15. Malvidin attenuates pain and inflammation in rats with osteoarthritis by suppressing NF-κB signaling pathway.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2017
    Article
  16. Tissue engineering. Part A · 2017
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Kenan ÖzlerDr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, Department of Orthopedics, Ankara, Turkey.
Erdem AktaşDr. Abdurrahman Yurtaslan Onkoloji Training and Research Hospital, Ankara, Turkey. Electronic address: drerdem2007@gmail.com.
Çiğdem AtayDr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, Department of Biochemistry, Ankara, Turkey.
Barış YılmazFatih Sultan Mehmet Training and Research Hospital, Department of Orthopedics, Istanbul, Turkey.
Murat ArıkanDr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, Department of Orthopedics, Ankara, Turkey.
Şafak GüngörDr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, Department of Orthopedics, Ankara, Turkey.
Ankara Onkoloji Eğitim ve Araştırma Hastanesi · TRFatih Sultan Mehmet Eğitim Ve Araştırma Hastanesi · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo compare the levels of MMP-13 and TNF-α in late stage osteoarthritis, define their predominant pathways and investigate their correlation with McMaster Universities Arthritis Index scores. PATIENTS AND

methodsA total of 42 patients (mean age 64 ± 8.8) with grade 3 and grade 4 knee osteoarthritis according to Kellegren- Lawrence criteria and who were scheduled for total knee arthroplasty were enrolled in the study. TNF-alpha and MMP-13 levels were measured preoperatively from venous blood samples and intraoperatively from knee synovial fluid via ELISA. Preoperative and 1 month postoperative knee functions were assessed by McMaster Universities Arthritis Index.

resultsGrade 4 synovial fluid MMP-13 (4.76 ± 5.82) was elevated compared to grade 3 (3.95 ± 4.45) (p = 0.438), whereas grade 3 serum MMP-13 (1.128 ± 0.308) was found elevated compared to grade 4 (1.038 ± 0.204) (p = 0.430). Grade 4 serum TNF-α (0.253 ± 0.277) was elevated compared to grade 3 (0.206 ± 0.219) whereas grade 3 synovial fluid TNF-α (0.129 ± 0.052) was elevated compared to grade 4 (0.118 ± 0.014). Positive correlation was observed between synovial fluid MMP-13 levels and postoperative WOMAC scores. Mean serum TNF-α level (0.226 ± 0.246 pg/ml) was found higher compared to synovial level (0.124 ± 1.59), synovial MMP-13 level (4.31 ± 1.24) was found higher compared to serum level (1.089 ± 1.519).

conclusionDespite the systemic increase in TNF-α levels concordant with osteoarthritis grade, MMP-13 levels are elevated via local manner with a significant correlation with WOMAC scores. LEVEL OF EVIDENCE: Level IV, Diagnostic study.

Indexed as

AgedArthroplasty, Replacement, KneeFemaleHumansMaleMatrix Metalloproteinase 13Middle AgedOsteoarthritis, KneePerioperative PeriodSerologic TestsSynovial FluidTumor Necrosis Factor-alphaMatrix Metalloproteinase 13MMP13 protein, humanTumor Necrosis Factor-alphaKnee osteoarthritisMatrix metalloproteinaseTNF-alpha

Identifiers

PMID27932045
PMCPMC6197357
OpenAlexW2344502660

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.